Everything about Retatrutide in Vietnam: how it works, what published research shows, regimens, reconstitution, risks — and the dated price from 2 200 000 ₫ with nationwide delivery.

| What it is | Retatrutide combines GIP, GLP-1 and glucagon receptor activity in one molecule. This triple mechanism connects appetite control with glucose regulatio… |
|---|---|
| Class | incretins (GLP-1/GIP/GCG) |
| Half-life | limited data |
| Vietnam price | from 2 200 000 ₫ (20 mg, index 2 November 2026) |
| Delivery | Da Nang ~30 min · country 1–2 days |
| Process | written confirmation before payment · VND/USD |
Retatrutide combines GIP, GLP-1 and glucagon receptor activity in one molecule. This triple mechanism connects appetite control with glucose regulation and energy metabolism.
An investigational triple-receptor agonist in clinical development for obesity and related metabolic conditions.
A prominent next-generation metabolic peptide with a triple mechanism and substantial phase 2 weight-loss results.
Understanding the mechanics separates an informed study from blind forum-following. Regimens, risks and data limits follow.

In the phase 2 obesity trial, the 12 mg group achieved average weight reduction of 24.2% at 48 weeks, compared with 2.1% for placebo. Exploratory measures also showed improvements in blood pressure, lipids and glucose-related markers.
Phase 2 research schedule: Subcutaneous administration once weekly. Target-dose groups: 1, 4, 8 or 12 mg weekly. Higher-dose groups began at 2 or 4 mg, depending on the arm, with protocol-defined escalation. Duration: 48 weeks. These are separate clinical-trial groups, not one dose ladder. Phase 3 schedules start at 2 mg and use their own escalation steps.
More: what lyophilizate is · vetting a seller · research-use-only meaning.
Retatrutide adds glucagon-receptor activity to GIP and GLP-1 signalling. That third pathway makes it a distinct metabolic research approach; separate trials should not be treated as a direct comparison. from 2 200 000 ₫ for 20 mg (index Nov 2, 2026); final total confirmed in writing before payment. No: research material, not a prescription drug; no medical claims. City pages: Da Nang · Nha Trang · Phu Quoc · Vung Tau · Da Lat · Hue · Mui Ne · Ha Long · Quy Nhon · Can Tho · Hai Phong · Hoi An Comparisons: Vs Semaglutide · Vs Cagrilintide · Vs Tirzepatide VNPEPS — a Vietnam-based VietPeptide project · Da Nang · Index: Nov 2, 2026 · Telegram @vietpep Research materials, not for human use. No medical advice. '+o.s+'
Nausea, diarrhoea and vomiting were the most frequent effects, often during escalation. Dose-dependent heart-rate increases were also observed; longer-term follow-up continues.
Category: research use only. Vet any seller: 8 checks.
Retatrutide combines GIP, GLP-1 and glucagon receptor activity in one molecule. This triple mechanism connects appetite control with glucose regulation and energy metabolism.
Phase 2 research schedule: Subcutaneous administration once weekly. Target-dose groups: 1, 4, 8 or 12 mg weekly. Higher-dose groups began at 2 or 4 mg, depending on the arm, with protocol-defined escalation. Duration: 48 weeks. These are separate clinical-tria
Precise data are limited — see the dossier sections.
from 2 200 000 ₫ for 20 mg per the dated index (2 November 2026). Totals fixed in writing per inquiry.
Da Nang ~30 minutes after confirmation; Ho Chi Minh City, Hanoi, Nha Trang and other cities 1–2 days. Named before payment.
Nausea, diarrhoea and vomiting were the most frequent effects, often during escalation. Dose-dependent heart-rate increases were also observed; longer-term follow-up continues.
🇻🇳 Vietnam-based project (Da Nang). Availability, final VND and delivery window — in writing before payment. Da Nang ~30 minutes, rest of Vietnam 1–2 days.